The impact of precision medicine in oncology

By Ryan Bookout, PharmD, OncLive

Ryan Bookout, PharmD, president, Hematology/Oncology Pharmacy Association, and clinical pharmacist, Moffitt Cancer Center, discusses the impact of recent advances made in the oncology space and how precision medicine is improving patient outcomes.

For decades, chemotherapy has been the standard of care for most cancers, but patient outcomes have not drastically changed over the years. However, with the recent progress made in molecular profiling and genetic testing, oncologists are doing a better job of integrating targeted therapies into practice. Read more …